Cargando…

Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study

OBJECTIVE: In Ethiopia, one-third of the estimated tuberculosis cases are not detected or reported. Incidence estimates are inaccurate and rarely measured directly. Assessing the ‘real’ incidence under programme conditions is useful to understand the situation. This study aimed to measure the preval...

Descripción completa

Detalles Bibliográficos
Autores principales: Banti, Abiot Bezabeh, Winje, Brita Askeland, Hinderaker, Sven Gudmund, Heldal, Einar, Abebe, Markos, Dangisso, Mesay Hailu, Datiko, Daniel Gemechu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387640/
https://www.ncbi.nlm.nih.gov/pubmed/37518077
http://dx.doi.org/10.1136/bmjopen-2022-070594
_version_ 1785081927829553152
author Banti, Abiot Bezabeh
Winje, Brita Askeland
Hinderaker, Sven Gudmund
Heldal, Einar
Abebe, Markos
Dangisso, Mesay Hailu
Datiko, Daniel Gemechu
author_facet Banti, Abiot Bezabeh
Winje, Brita Askeland
Hinderaker, Sven Gudmund
Heldal, Einar
Abebe, Markos
Dangisso, Mesay Hailu
Datiko, Daniel Gemechu
author_sort Banti, Abiot Bezabeh
collection PubMed
description OBJECTIVE: In Ethiopia, one-third of the estimated tuberculosis cases are not detected or reported. Incidence estimates are inaccurate and rarely measured directly. Assessing the ‘real’ incidence under programme conditions is useful to understand the situation. This study aimed to measure the prevalence and incidence of symptomatic pulmonary tuberculosis (PTB) during 1 year in the adult population of Dale in Ethiopia. DESIGN: A prospective population-based cohort study. SETTING: Every household in Dale was visited three times at 4-month intervals. PARTICIPANTS: Individuals aged ≥15 years. OUTCOME MEASURES: Microscopy smear positive PTB (PTB s+), bacteriologically confirmed PTB (PTB b+) by microscopy, GeneXpert, or culture and clinically diagnosed PTB (PTB c+). RESULTS: Among 136 181 individuals, 2052 had presumptive TB (persistent cough for 14 days or more with or without haemoptysis, weight loss, fever, night sweats, chest pain or difficulty breathing), in the first round of household visits including 93 with PTB s+, 98 with PTB b+ and 24 with PTB c+; adding those with PTB who were already on treatment, the total number of PTB was 201, and the prevalence was 147 (95% CI: 127 to 168)/100 000 population. Out of all patients with PTB, the proportion detected by symptom screening was in PTB s+ 65%, PTB b+ 67% and PTB c+44%. During 96 388 person-years follow-up, 1909 had presumptive TB, 320 had PTB and the total incidence of PTB was 332 (95% CI: 297 to 370)/100 000 person-years, while the incidence of PTB s+, PTB b+ and PTB c+ was 230 (95% CI: 201 to 262), 263 (95% CI: 232 to 297) and 68 (95% CI: 53 to 86)/100 000 person-years, respectively. CONCLUSION: The prevalence of symptomatic sputum smear-positive TB was still high, only one-third of prevalent PTB cases notified and the incidence rate highest in the age group 25–34 years, indicating ongoing transmission. Finding missing people with TB through repeated symptom screening can contribute to reducing transmission.
format Online
Article
Text
id pubmed-10387640
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103876402023-08-01 Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study Banti, Abiot Bezabeh Winje, Brita Askeland Hinderaker, Sven Gudmund Heldal, Einar Abebe, Markos Dangisso, Mesay Hailu Datiko, Daniel Gemechu BMJ Open Infectious Diseases OBJECTIVE: In Ethiopia, one-third of the estimated tuberculosis cases are not detected or reported. Incidence estimates are inaccurate and rarely measured directly. Assessing the ‘real’ incidence under programme conditions is useful to understand the situation. This study aimed to measure the prevalence and incidence of symptomatic pulmonary tuberculosis (PTB) during 1 year in the adult population of Dale in Ethiopia. DESIGN: A prospective population-based cohort study. SETTING: Every household in Dale was visited three times at 4-month intervals. PARTICIPANTS: Individuals aged ≥15 years. OUTCOME MEASURES: Microscopy smear positive PTB (PTB s+), bacteriologically confirmed PTB (PTB b+) by microscopy, GeneXpert, or culture and clinically diagnosed PTB (PTB c+). RESULTS: Among 136 181 individuals, 2052 had presumptive TB (persistent cough for 14 days or more with or without haemoptysis, weight loss, fever, night sweats, chest pain or difficulty breathing), in the first round of household visits including 93 with PTB s+, 98 with PTB b+ and 24 with PTB c+; adding those with PTB who were already on treatment, the total number of PTB was 201, and the prevalence was 147 (95% CI: 127 to 168)/100 000 population. Out of all patients with PTB, the proportion detected by symptom screening was in PTB s+ 65%, PTB b+ 67% and PTB c+44%. During 96 388 person-years follow-up, 1909 had presumptive TB, 320 had PTB and the total incidence of PTB was 332 (95% CI: 297 to 370)/100 000 person-years, while the incidence of PTB s+, PTB b+ and PTB c+ was 230 (95% CI: 201 to 262), 263 (95% CI: 232 to 297) and 68 (95% CI: 53 to 86)/100 000 person-years, respectively. CONCLUSION: The prevalence of symptomatic sputum smear-positive TB was still high, only one-third of prevalent PTB cases notified and the incidence rate highest in the age group 25–34 years, indicating ongoing transmission. Finding missing people with TB through repeated symptom screening can contribute to reducing transmission. BMJ Publishing Group 2023-07-30 /pmc/articles/PMC10387640/ /pubmed/37518077 http://dx.doi.org/10.1136/bmjopen-2022-070594 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Banti, Abiot Bezabeh
Winje, Brita Askeland
Hinderaker, Sven Gudmund
Heldal, Einar
Abebe, Markos
Dangisso, Mesay Hailu
Datiko, Daniel Gemechu
Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study
title Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study
title_full Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study
title_fullStr Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study
title_full_unstemmed Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study
title_short Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study
title_sort prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in ethiopia: a prospective cohort study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387640/
https://www.ncbi.nlm.nih.gov/pubmed/37518077
http://dx.doi.org/10.1136/bmjopen-2022-070594
work_keys_str_mv AT bantiabiotbezabeh prevalenceandincidenceofsymptomaticpulmonarytuberculosisbasedonrepeatedpopulationscreeninginadistrictinethiopiaaprospectivecohortstudy
AT winjebritaaskeland prevalenceandincidenceofsymptomaticpulmonarytuberculosisbasedonrepeatedpopulationscreeninginadistrictinethiopiaaprospectivecohortstudy
AT hinderakersvengudmund prevalenceandincidenceofsymptomaticpulmonarytuberculosisbasedonrepeatedpopulationscreeninginadistrictinethiopiaaprospectivecohortstudy
AT heldaleinar prevalenceandincidenceofsymptomaticpulmonarytuberculosisbasedonrepeatedpopulationscreeninginadistrictinethiopiaaprospectivecohortstudy
AT abebemarkos prevalenceandincidenceofsymptomaticpulmonarytuberculosisbasedonrepeatedpopulationscreeninginadistrictinethiopiaaprospectivecohortstudy
AT dangissomesayhailu prevalenceandincidenceofsymptomaticpulmonarytuberculosisbasedonrepeatedpopulationscreeninginadistrictinethiopiaaprospectivecohortstudy
AT datikodanielgemechu prevalenceandincidenceofsymptomaticpulmonarytuberculosisbasedonrepeatedpopulationscreeninginadistrictinethiopiaaprospectivecohortstudy